Major publication in Nature Communications with our drug that contains both preclinical/scientific and clinical trial data. Puts together the many pieces of the puzzle we have been working over the past few years at EIP, and provides foundation for taking our drug into confirmatory clinical trials in patients with dementia with Lewy bodies. Read the publication here: https://rdcu.be/cV0Ro
This is a major paper that should shake the foundations of the field. This is the way science is supposed to be done: sufficientLy iconoclastic to be real progress and meticulous intellectual and experimental integrity to back it up.
Congratulations John!
Amazing news, John! Wishing you all the best!
Congratulations John, Fanastic to see this.
Congratulations John!
Congratulations John and team. Great to hear about the progress you are making for such a good cause
Congratulations John!
Congrats John Alam and Sylvie Gregoire!
John, congratulations to you and the team
Bravo!